Advertisement
Canada markets closed
  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CAD/USD

    0.7273
    +0.0009 (+0.13%)
     
  • CRUDE OIL

    83.20
    +0.47 (+0.57%)
     
  • Bitcoin CAD

    88,447.31
    +1,232.16 (+1.41%)
     
  • CMC Crypto 200

    1,381.36
    +68.74 (+5.24%)
     
  • GOLD FUTURES

    2,402.70
    +4.70 (+0.20%)
     
  • RUSSELL 2000

    1,940.29
    -2.67 (-0.14%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     
  • VOLATILITY

    19.01
    +1.01 (+5.61%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6823
    +0.0002 (+0.03%)
     

Is It Too Late to Buy Novavax Stock?

Is It Too Late to Buy Novavax Stock?

This month, the U.S. government awarded Novavax (NASDAQ: NVAX) more funding than any other company in the coronavirus vaccine race. Operation Warp Speed, the government's effort to help bring a vaccine to market by January, awarded the biotech company $1.6 billion. The move surprised the market, as Novavax wasn't on the government's list of five companies to potentially receive funding.